1996
DOI: 10.1136/bjo.80.8.759
|View full text |Cite
|
Sign up to set email alerts
|

Use of physical barriers for delayed adjustable strabismus surgery: the effect of interceed and polyglactin 910 mesh.

Abstract: Aimslbackground-In the course of adjustable strabismus surgery there is only a limited period after surgery before the formation of firm adhesions prevents successful adjustment. To determine if this period could be increased by the interposition of suitable physical barriers, the use of Interceed and polyglactin 910 mesh was investigated in an aniimal model. Methods-A total of 39 rabbit eyes were divided into three groups. After recession of the superior rectus muscle (SRM), balanced salt solution was applied… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
16
1

Year Published

2004
2004
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(17 citation statements)
references
References 15 publications
0
16
1
Order By: Relevance
“…These adhesions are normally located between the muscle whose sheath was ruptured and the scleral surface, conjunctiva, Tenon's capsule or orbital fat, leading to cicatricial strabismus. 13,14 Several procedures to prevent these undesired cicatricial events have been proposed and include physical barriers such as a gelatinous sponge obtained from animal skin, 8,15 synthetic peptides, 16 polyglactin 910-based materials, 17 viscoelastic substances, Tenon's capsule, and silicone. 18 The use of antifibrotic drugs such as mitomycin C, 13,17,19,20 daunorubicin, 19 bleomycin, 19 mitramycin, 19 5-fluorouracil, 21 and cyanoacrylate 18 has also been suggested.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…These adhesions are normally located between the muscle whose sheath was ruptured and the scleral surface, conjunctiva, Tenon's capsule or orbital fat, leading to cicatricial strabismus. 13,14 Several procedures to prevent these undesired cicatricial events have been proposed and include physical barriers such as a gelatinous sponge obtained from animal skin, 8,15 synthetic peptides, 16 polyglactin 910-based materials, 17 viscoelastic substances, Tenon's capsule, and silicone. 18 The use of antifibrotic drugs such as mitomycin C, 13,17,19,20 daunorubicin, 19 bleomycin, 19 mitramycin, 19 5-fluorouracil, 21 and cyanoacrylate 18 has also been suggested.…”
Section: Introductionmentioning
confidence: 99%
“…13,14 Several procedures to prevent these undesired cicatricial events have been proposed and include physical barriers such as a gelatinous sponge obtained from animal skin, 8,15 synthetic peptides, 16 polyglactin 910-based materials, 17 viscoelastic substances, Tenon's capsule, and silicone. 18 The use of antifibrotic drugs such as mitomycin C, 13,17,19,20 daunorubicin, 19 bleomycin, 19 mitramycin, 19 5-fluorouracil, 21 and cyanoacrylate 18 has also been suggested. Mitomycin C, isolated by Wakaki et al 22 through the fermentation of Streptomyces caespitasus, was classified as an antibiotic and antineoplastic agent able to inhibit DNA, RNA and protein synthesis, cause partial impairment of fibroblast proliferation, and promote degradation of preformed DNA promoting cell nuclear lysis.…”
Section: Introductionmentioning
confidence: 99%
“…After that, researchers tried absorbable mechanical barriers. For this purpose, polydioxanone, polytetrafluoroethylene, Seprafilm, polyglactin 910 sheath, SurgiWrap, and sodium hyaluronate and hydroxypropyl methylcellulose among viscoelastic materials have been used (8)(9)(10)(11)(12)(13)(14). Complications such as foreign body reaction and infection have been encountered minimally with these materials; however, their efficacy against adhesion formation was found to be inadequate.…”
Section: Discussionmentioning
confidence: 99%
“…Efforts have been made to facilitate delayed adjustment by implanting physical barriers such as silicone, 5,6 viscoelastic material, 7 oxidized regenerated cellulose compound (InterceedTC7; Johnson & Johnson Medical, Arlington, Texas), 8 polyglactin 910 mesh, 8 polytetrafluoroethylene (PTFE; W.L. Gore & Associates, Flagstaff, AZ), 9 or bioresorbable sheet (SurgiWrap; MacroPore Biosurgery, Inc, San Diego, CA), 10 by using antiproliferative agents such as mitomycin C, 11 or by using combinations of these various physical barriers and antiproliferative agents.…”
mentioning
confidence: 99%